You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Baxter
Moodys
Dow
McKinsey

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

Details for Biologics License Application: 206538


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Summary for BLA: 206538
Tradename:TOUJEO MAX SOLOSTAR
Applicant:Sanofi Us Services
Ingredient:insulin glargine recombinant
Patents:4
Approval Date:Sep 29, 2015
Suppliers: see list1

US Patents for BLA: 206538

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Sanofi Us Services TOUJEO SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 001 2015-09-29   Start Trial ForSight Vision4, Inc. (South San Francisco, CA) 2029-01-29 RX search
Sanofi Us Services TOUJEO SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 001 2015-09-29   Start Trial ForSight Vision4, Inc. (Menlo Park, CA) 2029-01-29 RX search
Sanofi Us Services TOUJEO SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 001 2015-09-29   Start Trial Forsight Vision4, Inc. (Menlo Park, CA) 2029-01-29 RX search
Sanofi Us Services TOUJEO SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 001 2015-09-29   Start Trial Corning Incorporated (Corning, NY) 2031-10-25 RX search
Sanofi Us Services TOUJEO MAX SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 002 2015-09-29   Start Trial ForSight Vision4, Inc. (South San Francisco, CA) 2029-01-29 RX search
Sanofi Us Services TOUJEO MAX SOLOSTAR insulin glargine recombinant SOLUTION;SUBCUTANEOUS 206538 002 2015-09-29   Start Trial ForSight Vision4, Inc. (Menlo Park, CA) 2029-01-29 RX search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Johnson and Johnson
Mallinckrodt
AstraZeneca
Colorcon
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.